Aurinia Pharmaceuticals Inc (NASDAQ:AUPH)

Delayed Data
As of Oct 06
 +0.08 / +1.06%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 8 analysts offering 12-month price forecasts for Aurinia Pharmaceuticals Inc have a median target of 21.50, with a high estimate of 30.00 and a low estimate of 13.00. The median estimate represents a +181.78% increase from the last price of 7.63.

Analyst Recommendations

The current consensus among 8 polled investment analysts is to Buy stock in Aurinia Pharmaceuticals Inc. This rating has held steady since July, when it was unchanged from a Buy rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
Nov 15

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 7.20%
Growthannually 41.43%


Growthquarterly 14.96%
Growthannually 157.22%
Key to the earnings and sales forecast charts.